Abiopharma

News list

Renner Alexandra 🟡 adjusted position in 0 shares (1 derivative) of Oklo Inc. (OKLO) Transaction Date: Aug 31, 2026 | Filing ID: 000004

Full text

News bot Sept. 1, 2026, 8:44 p.m.
🔍 Renner Alexandra (Executive)

Company: Oklo Inc. (OKLO)

Report Date: 2026-08-31
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 4,173
- Total shares sold: 4,173
- Total shares held: 123,153
Detailed Transactions and Holdings:
- Acquired 4,173 shares of Class A Common Stock (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 476,952.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-31 | Code: H | nature_of_ownership: Joint account with spouse | shares_owned_after: 123,153.00
- Sold 4,173 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 48,001.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2: On June 22, 2026 the Reporting Person was granted 52,174 RSUs, vesting on August 27, 2026 and continuing to vest thereafter in 12 substantially equal quarterly installments. On August 31, 2026, 4,173 RSUs were distributed.